|
HTATSF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.322100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.794300E-02 |
| Normal-vs-Stage2 |
2.390200E-01 |
| Normal-vs-Stage3 |
2.079200E-01 |
| Normal-vs-Stage4 |
2.315100E-03 |
| Stage1-vs-Stage2 |
8.146000E-01 |
| Stage1-vs-Stage3 |
6.880400E-01 |
| Stage1-vs-Stage4 |
3.086500E-02 |
| Stage2-vs-Stage3 |
9.313000E-01 |
| Stage2-vs-Stage4 |
2.449800E-02 |
| Stage3-vs-Stage4 |
2.576100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.940200E-02 |
| Normal-vs-AfricanAmerican |
4.219600E-01 |
| Normal-vs-Asian |
8.936200E-01 |
| Caucasian-vs-AfricanAmerican |
2.517000E-01 |
| Caucasian-vs-Asian |
3.901600E-01 |
| AfricanAmerican-vs-Asian |
7.856200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.440900E-03 |
| Normal-vs-Female |
6.758000E-01 |
| Male-vs-Female |
8.49139999999915E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.159500E-02 |
| Normal-vs-Extreme_Weight |
4.918100E-03 |
| Normal-vs-Obese |
2.946200E-01 |
| Normal-vs-Extreme_Obese |
1.597840E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.895000E-01 |
| Normal_Weight-vs-Obese |
4.128200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.755600E-01 |
| Extreme_Weight-vs-Obese |
7.894100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.589200E-01 |
| Obese-vs-Extreme_Obese |
4.419600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.098600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.574240E-01 |
| Normal-vs-Age(61-80Yrs) |
2.846400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.426800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.819000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.032200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.732800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.273600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.960200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.725200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.487390E-01 |
| Normal-VS-Type2 PRCC |
1.328110E-02 |
| Normal-VS-KIRP CIMP |
1.284020E-01 |
| Normal-VS-Unclassified PRCC |
1.982180E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.252400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.056800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.931000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.743000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.257000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.487200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.677600E-02 |
| Normal-vs-N1 |
1.639000E-01 |
| Normal-vs-N2 |
1.714780E-01 |
| N0-vs-N1 |
6.543200E-01 |
| N0-vs-N2 |
6.627200E-01 |
| N1-vs-N2 |
5.046400E-01 |
|
|
